149 related articles for article (PubMed ID: 8807259)
41. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression.
Maiorana A; Cavallari V; Bagni A; Ussia F; Maiorana MC; Fano RA
Anal Cell Pathol; 1996 Aug; 11(3):199-209. PubMed ID: 8888955
[TBL] [Abstract][Full Text] [Related]
42. [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study].
Zhou ZW; Wan DS; Wang GQ; Pan ZZ; Lu HP; Gao JH; Ding PR
Ai Zheng; 2004 Jul; 23(7):851-4. PubMed ID: 15248927
[TBL] [Abstract][Full Text] [Related]
43. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring.
Kohlberger PD; Kieback DG; Breitenecker F; Loesch A; Gitsch G; Kainz C; Breitenecker G
Gynecol Oncol; 1997 Mar; 64(3):404-10. PubMed ID: 9062141
[TBL] [Abstract][Full Text] [Related]
44. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S
Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528
[TBL] [Abstract][Full Text] [Related]
45. Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
Balleine RL; Earl MJ; Greenberg ML; Clarke CL
Br J Cancer; 1999 Mar; 79(9-10):1564-71. PubMed ID: 10188907
[TBL] [Abstract][Full Text] [Related]
46. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP
Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755
[TBL] [Abstract][Full Text] [Related]
47. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
48. [Western blot analysis and flow cytometric analysis of estrogen and progesterone receptors in fixed breast cancer cells].
Tao DD; Jiang M; Wu JH; Feng YD; Gong JP
Ai Zheng; 2004 Mar; 23(3):339-41. PubMed ID: 15025971
[TBL] [Abstract][Full Text] [Related]
49. [Expression of estrogen and progesterone receptors and oncoprotein HER-2 as a marker for clinical course and outcome in endometrioid adenocarcinoma of the uterine body (immunohistologic study)].
Samsonova EA; Maksimova NA; Urmancheeva AF; Pozharisskiĭ KM
Vopr Onkol; 2004; 50(2):196-201. PubMed ID: 15176223
[TBL] [Abstract][Full Text] [Related]
50. [Immunohistochemical characteristics of mammary carcinomas with estrogen-negative and progesterone-positive receptors].
Sundblad AS; Caprarulo L
Medicina (B Aires); 1996; 56(6):683-9. PubMed ID: 9284572
[TBL] [Abstract][Full Text] [Related]
51. Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones.
Qiu J; Kulkarni S; Chandrasekhar R; Rees M; Hyde K; Wilding G; Tan D; Khoury T
Am J Clin Pathol; 2010 Nov; 134(5):813-9. PubMed ID: 20959666
[TBL] [Abstract][Full Text] [Related]
52. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
Skasko E; Paszko Z; Mazur S
Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
[TBL] [Abstract][Full Text] [Related]
53. Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status.
Martín de las Mulas J; Van Niel M; Millán Y; Ordás J; Blankenstein MA; Van Mil F; Misdorp W
Res Vet Sci; 2002 Apr; 72(2):153-61. PubMed ID: 12027597
[TBL] [Abstract][Full Text] [Related]
54. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S
Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568
[TBL] [Abstract][Full Text] [Related]
55. Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy.
Cahill RA; Walsh D; Landers RJ; Watson RG
Ann Surg Oncol; 2006 Jan; 13(1):45-51. PubMed ID: 16378157
[TBL] [Abstract][Full Text] [Related]
56. Prognostic implications of HER-2 status in steroid receptor-positive, lymph node-negative breast carcinoma.
Peiró G; Adrover E; Aranda FI; Peiró FM; Niveiro M; Sánchez-Payá J
Am J Clin Pathol; 2007 May; 127(5):780-6. PubMed ID: 17439837
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical expressions of estrogen and progesterone receptors in human epididymis at different ages--a preliminary study.
Misao R; Fujimoto J; Niwa K; Morishita S; Nakanishi Y; Tamaya T
Int J Fertil Womens Med; 1997; 42(1):39-42. PubMed ID: 9113834
[TBL] [Abstract][Full Text] [Related]
58. Progesterone receptor detection in paraffin sections of human breast cancers by an immunoperoxidase technique incorporating microwave heating.
Goldberg DE; Stuart J; Koerner FC
Mod Pathol; 1994 Apr; 7(3):401-6. PubMed ID: 8058716
[TBL] [Abstract][Full Text] [Related]
59. Brief fixation does not affect assessment of hormone receptor expression in invasive breast carcinoma biopsies: paving the road for same-day tissue diagnostics.
Kalkman S; Barentsz MW; Witkamp AJ; van der Wall E; Verkooijen HM; van Diest PJ
Am J Surg Pathol; 2014 Aug; 38(8):1071-8. PubMed ID: 24705310
[TBL] [Abstract][Full Text] [Related]
60. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
